United States

  • Resistance Map
  • Resistance Trend
  • Resistance Chart
  • Use Map
  • Use Trend
  • Use Chart
Data includes aggregated resistance rates for isolates (includes intermediate resistance) from blood and cerebrospinal fluid (i.e., invasive) from inpatients of all ages. Because of differences in scope of collections and testing methods, caution should be exercised in comparing across countries. For more details see methodology.
Antibiotic use data are shown in prescriptions per 1,000 individuals. View data as defined daily doses (DDD)
Country boundaries/designations do not represent CDDEP opinion concerning the legal status of any country, territory, city, or area of its authorities, or concerning the delimitation of its frontiers or boundaries.
Hide Errorbars

Pathogens
Antibiotics

Sources

Data analytics for United States Data provided by BD Insights. To learn more about BD Insights research analytics and the most recent quarterly AMR data please contact bdinsights@bd.com and visit http://AMR.BD.com to learn about BD's efforts to help combat AMR.

To learn how this data was collected, see our methodology overview.
Boundaries and names shown and the designation used on these maps do not imply the expression of any opinion whatsoever on the part of CDDEP concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries.

Citing ResistanceMap
Please cite data or figures from ResistanceMap in the following style: The Center for Disease Dynamics Economics & Policy. ResistanceMap: [Page Name]. 2018. [URL]. Date accessed: [Date].
Example: 1. The Center for Disease Dynamics Economics & Policy. ResistanceMap: Antibiotic resistance. 2018. https://resistancemap.cddep.org/CountryPageSub.php?country=United States. Date accessed: May 31, 2018.